Biolife Solutions (BLFS) Total Non-Current Liabilities (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Total Non-Current Liabilities data on file, last reported at $28.5 million in Q1 2026.

• Quarterly Total Non-Current Liabilities changed N/A year-over-year to $28.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.5 million (changed N/A YoY) and the FY2025 annual result came in at $33.8 million, down 33.12% from the prior year.
• Total Non-Current Liabilities retreated to $28.5 million in Q1 2026 per BLFS's latest filing, from $33.8 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $86.5 million in Q1 2023 and bottomed at $28.5 million in Q1 2026.
• The 5-year median for Total Non-Current Liabilities is $75.1 million (2023), against an average of $65.7 million.
• The widest annual swing landed in 2022, when Total Non-Current Liabilities jumped 115.4%; it then tumbled 33.12% in 2025.
• Tracing BLFS's Total Non-Current Liabilities over 5 years: stood at $86.0 million in 2022, then decreased by 12.76% to $75.1 million in 2023, then slumped by 32.61% to $50.6 million in 2024, then sank by 33.12% to $33.8 million in 2025, then retreated by 15.76% to $28.5 million in 2026.
• Per Business Quant, the three latest BLFS Total Non-Current Liabilities figures stand at $28.5 million (Q1 2026), $33.8 million (Q4 2025), and $50.6 million (Q4 2024).

Peer Comparison